Cyient is currently trading at Rs. 390.45, up by 11.20 points or 2.95% from its previous closing of Rs. 379.25 on the BSE.
The scrip opened at Rs. 382.60 and has touched a high and low of Rs. 395.15 and Rs. 382.60 respectively. So far 17676 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 514.00 on 06-Feb-2020 and a 52 week low of Rs. 184.15 on 22-May-2020.
Last one week high and low of the scrip stood at Rs. 398.00 and Rs. 369.25 respectively. The current market cap of the company is Rs. 4293.83 crore.
The promoters holding in the company stood at 23.25%, while Institutions and Non-Institutions held 56.71% and 20.04% respectively.
Cyient has entered into a manufacturing partnership with Agappe to bring to market Count X. The Mispa Count X is an indigenously designed and developed three-part hematology analyzer by Agappe, which will make India self-reliant in hematology and enable the setup of well-equipped labs in remote and rural locations across India. The company will manufacture certain key components of Mispa Count X at its ISO 13485-certified, state-of-art manufacturing facilities in India.
Cyient provides engineering, manufacturing, geospatial, network and operations management services to global industry leaders. It leverages the power of digital technology and advanced analytics capabilities, along with domain knowledge and technical expertise, to solve complex business problems.
Company Name | CMP |
---|---|
TCS | 3883.55 |
Infosys | 1498.80 |
HCL Tech. | 1543.30 |
Wipro | 480.05 |
Tech Mahindra | 1250.40 |
View more.. |